432
Views
36
CrossRef citations to date
0
Altmetric
Research Article

A novel microparticulate vaccine for melanoma cancer using transdermal delivery

, , , , &
Pages 294-300 | Received 06 Jan 2011, Accepted 24 Jan 2011, Published online: 17 May 2011

References

  • Ahsan F, Rivas IP, Khan MA, Suarez AI. Targeting to macrophages: Role of physicochemical properties of particulate carriers-liposomes and microparticles – on the phagocytosis of microparticles. J Controlled Release 2002; 79: 29–40
  • Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245–52
  • Benakanakere MR, Li Q, Eskan MA, Singh AV, Zhao J, Gallicia JC, Kinane DF. Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem 2009; 284(34)23107–15
  • Benencia F, Courreges MC, Garcia JRC, Hadley AM. Direct vaccination with tumor cells killed with ICP4-deficient HSVd120 elicits effective antitumor immunity. Cancer Biol Ther 2006; 5(7)867–75
  • Bockman DE, Cooper MD. Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricus, appendix and Peyer's patches. An electronic microscopic study. Am J Anat 1973; 136: 455–77
  • Bramwell VW, Perrie Y. Particulate delivery systems for vaccines. Crit Rev Ther Drug Carrier Syst 2005; 22(2)151–214
  • Bumgarner GW. 2001. Evaluation of the microparticle as an adjuvantaor coadjuvant in a tumor vaccine. PhD Thesis, Mercer University, US
  • Campbell A, Bondy SC. Aluminum-induced oxidative events and its relation to inflammation: A role for the metal in Alzheimer's disease. Cell Mol Biol 2000; 46: 721–30
  • Coulman S, Allender C, Birchall J. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit Rev Ther Drug Carrier Syst 2006a; 23(3)205–58
  • Coulman SA, Barrow D, Anstey A, Gateley C, Morrissey A, Wilke N, Allender C, Brain K, Birchall JC. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. Curr Drug Deliv 2006b; 3(1)65–75
  • Cui Z, Dierling A, Foldvari M. Non-invasive immunization on the skin using DNA vaccine. Curr Drug Deliv 2006; 3: 29–35
  • D’Souza MJ, DeSouza PJ. Site specific microencapsulated drug targeting strategies to the liver and the gastrointestinal tract. Adv Drug Deliv Rev 1995; 17: 247–54
  • D'Souza M, Pourfarzib R. Improved efficacy of a microencapsulated macrophage colony stimulating factor and methotrexate in melanoma. Drug Dev Ind Pharm 1999; 25(5)583–90
  • Fukao T, Koyasu S. Expression of functional IL-2 receptors on mature splenic dendritic cells. Eur J Immunol 2000; 30: 1453–7
  • Goldsby RA, Kindt TJ, Osborne BA, Kuby J. Immunology. W.H. Freeman and Company, New York 2000; 161–80
  • Jaffee EM. Immunotherapy of cancer. Ann NY Acad Sci 1999; 886: 67–72
  • Kaushik S, Hord AH, Denson DD, McAllister DV, Smithra S, Allen MG, Prausnitz MR. Lack of pain associated with microfabricated microneedles. Anesth Analg 2001; 92(2)502–4
  • Kubin M, Kamoun M, Trinchieri G. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med 1994; 180: 211–22
  • Mahe B, Vogt A, Liard C, Duffy D, Sterry W, Verrier B. Nano particle based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. J Invest Dermatol 2009; 129: 1156–64
  • Martanto W, Davis S, Holiday N, Wang J, Gill H, Prausnitz M. Transdermal delivery of insulin using microneedles in vivo. Pharm Res 2004; 21(6)947–52
  • McAllister DV, Wang PM, Davis SP, Park JH, Canatella PJ, Allen MG, Prausnitz MR. Microfabricated needles for transdermal delivery of macromolecules and nanoparticle: Fabrication methods and transport studies. Proc Nat Acad Sci USA 2003; 100(24)13755–60
  • Morton DL, Barth A. Vaccine therapy for malignant melanoma. Cancer J Clin 1996; 46: 225–44
  • Nordquist L, Roxhed N, Griss P. Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control: An initial comparison with subcutaneous administration. Pharm Res 2007; 24(7)1381–8
  • Park JH, Allen M, Prausnitz M. Biodegradable polymer microneedles: Fabrication, mechanisms and transdermal drug delivery. J Controlled Release 2005; 104(1)51–66
  • Partidos CD, Muller S. Decision making at the surface of the intact or barrier disrupted skin: Potential applications for vaccination or therapy. Cell Mol Life Sci 2005; 62(13)1418–24
  • Peter IA, Mezzacasa LP, Dummer R. Comparative analysis of immunocritical melanoma markers in the mouse melanoma cell lines B16, K1735 and S91-M3. Melanoma Res 2001; 11: 21–30
  • Pulendran B, Manicassamy S. Modulation of adaptive immunity with Toll-like receptors. Semin Immunol 2009; 21(4)185–93
  • Shi Z, Curiel DT, Tang D. DNA based non-invasive vaccination onto the skin. Vaccine 1999; 17: 2136–41
  • Streilein JW. Skin-associated lymphoid tissues (SALT): Origins and functions. J Invest Dermatol 1983; 80: 12–16
  • Tabata Y, Ikada Y. Effects of the size and surface charge of polymer microparticles on their phagocytosis by macrophages. Biomaterials 1988; 9: 356–62
  • Trinchieri G, Scott P. Interleukin-12: Basic principles and clinical applications. Curr Top Microbiol Immunol 1999; 238: 57–78
  • Uddin M, Duc PD, Pai BS, Gayakwad S, Oettinger CW, D’Souza MJ. A methodology for quantitation and characterization of oligonucleotides in albumin microparticles. The Analyst 2009; 134(7)1483–9
  • Yin HL, D’Souza MJ. Formulation and evaluation of an oral melanoma vaccine. J Microencapsul 2007; 24(3)235–52
  • Zinkernagel RM, Ehl S, Aichele P, Oehen S, Kundig T, Hengartner H. Antigen localization regulates immune responses in a dose- and time-dependent fashion: A geographical review of immune reactivity. Immunol Rev 1997; 156: 199–209

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.